- Home
- CRNT vs GALT Comparison
CRNT vs GALT Comparison
Compare CRNT & GALT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CRNT | GALT |
|---|---|---|
| Founded | 1996 | 2000 |
| Country | Israel | United States |
| Employees | N/A | N/A |
| Industry | Radio And Television Broadcasting And Communications Equipment | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 189.7M | 203.7M |
| IPO Year | 2000 | N/A |
Fundamental Metrics
Financial Performance| Metric | CRNT | GALT |
|---|---|---|
| Price | $2.27 | $3.14 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 3 |
| Target Price | $4.00 | ★ $8.50 |
| AVG Volume (30 Days) | ★ 652.1K | 438.7K |
| Earning Date | 02-10-2026 | 11-14-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.02 | N/A |
| Revenue | ★ $363,330,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $6.22 | N/A |
| P/E Ratio | $146.42 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.82 | $1.12 |
| 52 Week High | $5.52 | $7.13 |
Technical Indicators
Market Signals| Indicator | CRNT | GALT |
|---|---|---|
| Relative Strength Index (RSI) | 53.23 | 36.40 |
| Support Level | $2.23 | $2.93 |
| Resistance Level | $2.39 | $3.56 |
| Average True Range (ATR) | 0.09 | 0.27 |
| MACD | 0.00 | 0.07 |
| Stochastic Oscillator | 54.10 | 20.48 |
Price Performance
Historical ComparisonAbout CRNT Ceragon Networks Ltd.
Ceragon Networks Ltd is a wireless transport company in terms of unit shipments and wide distribution of its business, providing high-capacity wireless connectivity solutions to markets across various industries, mainly wireless (mobile) networks service providers. Geographically the company generates the key revenue from India. The company also has presence in North America, Europe, Africa, Asia-Pacific and Middle East, and Latin America. The company's products include IP-50 Platform, IP-20 Platform, Pointlink.
About GALT Galectin Therapeutics Inc.
Galectin Therapeutics Inc is a clinical-stage biopharmaceutical company. The company focuses on drug research and development to create new therapies for fibrotic disease, cancer, and selected other diseases. Its galectin-3 inhibitor is belapectin (GR-MD-02), which has been demonstrated in preclinical models to reverse liver fibrosis and cirrhosis.